InVasc Therapeutics, founded in 2006, develops drugs for cardiometabolic conditions, transitioning from a start-up to a seasoned pharmaceutical organization.
How does InVasc Therapeutics compare with TheraVasc, Rivus Pharmaceuticals, and Vasa Therapeutics?
It depends on what you need. InVasc Therapeutics focuses on Drugs, serves Enterprise customers, is based in Tucker, GA, US, and has raised $3.1M (last round: Series A). TheraVasc focuses on Drugs and Pharmaceuticals, serves Consumers and Enterprise customers, is based in Cleveland, OH, US, and has raised $3.4M (last round: Series Unknown). Rivus Pharmaceuticals focuses on Pharmaceuticals and Therapeutics, serves Enterprise customers, is based in Charlottesville, VA, US, and has raised $167M (last round: Series B). Vasa Therapeutics focuses on Therapeutics, serves Enterprise customers, is based in San Diego, CA, US, and has raised $8.3M (last round: Seed).
